May 2018 Newsletter

May 24, 2018:

ARVO Highlights Gene Therapies, Diagnostics in Call to Action to Defend Vision Science

Jennifer Doudna, PhD, described to a packed crowd her journey in discovering the application of CRISPR-Cas gene editing to humans.

May 24, 2018:

White House Proposes Private-Payer Negotiation in Medicare Part B

Proposal is one of more than 50 outlined in ‘blueprint’ for addressing rising drug prices.

May 24, 2018:

Valeant to Rebrand as Bausch Health Companies in July

The Bausch + Lomb eye care division will keep its historic name.

May 24, 2018:

US Supreme Court Denies Petition to Hear Eye Drop Case

Alcon, Allergan, and Bausch + Lomb petitioned the high court to hear the case.

May 24, 2018:

Supreme Court Upholds Inter Partes Review Process for Challenging Patents

Patent challengers had a win rate of 64 percent in cases that reached a final decision in 2017, legal advisers say.

May 24, 2018:

Aerie Launches Rhopressa in US as Treatment for Lowering IOP in Glaucoma Patients

The company also filed an NDA for Roclatan, a fixed-dose combination of Rhopressa and latanoprost.

May 24, 2018:

2018 ARVO Meeting: Factors with Immediate Effect on Vision Include Lighting, Foods, Research Shows

The time of day when one reads could cause myopia, according to scientists in Australia.

May 24, 2018:

2018 ARVO Meeting: Trade Show Reveals High Interest in Gene-Testing Technology

Companies exhibiting drug and device candidates said routine use in the clinic is on the horizon.

May 24, 2018:

2018 ARVO Meeting: Research Suggests Two Revolutions on the Horizon for Retinal Disease

Regenerative medicine and patient care were common themes throughout agenda.

May 24, 2018:

iSTAR Announces ‘Promising’ Early-Stage Results for MINIject MIGS Device

The MIGS device is designed to increase aqueous humor outflow from the anterior chamber to the supraciliary space.

May 24, 2018:

Report: HCA Makes Bid for Envision, Aims to Take Over AmSurg

Nashville-based Envision has asked potential acquirers to submit final offers later this month.

May 24, 2018:

Keopsys Quantel Group Changes Name to Lumibird

Quantel Group, maker of ophthalmic laser technology, combined with Keopsys Group in October 2017.

May 24, 2018:

FDA Publishes List of Companies Accused of Blocking Access to Drug Samples for Generic Development

The agency said the information will be updated a semi-annual basis.

May 24, 2018:

WOC2018 to Draw Ophthalmologists from 109 Countries to Barcelona

The scientific program features 350 sessions across all ophthalmic subspecialties.

May 24, 2018:

Market Report: Ultrasonic Phaco Remains Dominant, but New Technologies Ready to Challenge

Dedicated machine packs and accessories will make up a large part of the $1.6 billion in global cataract equipment revenues in 2018.

May 24, 2018:

Market Report: Ophthalmic OR Microscope Market to See More Than 6 Percent Growth over Next Five Years

Revenues will rise most sharply in Latin America and other developing regions due to expanding access to ophthalmic surgery.

May 24, 2018:

Takeda Makes Firm $62.2B Bid for Shire

The deal is expected to close in the first half of 2019.

May 24, 2018:

Market Scope Weekly Polls

May 24, 2018:

Chinese Biotech Innovent Raises $150 Million; Other Firms Raise $78.8 Million

Additional companies that announced deals included Avedro, NeuroVision, Wuxi Vision Pro, Second Sight, and Surface.

May 24, 2018:

May 2018 News Briefs

Social media